PMI BioPharma Solutions Revenue and Competitors

Location

$23.6M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • PMI BioPharma Solutions's estimated annual revenue is currently $22.5M per year.(i)
  • PMI BioPharma Solutions's estimated revenue per employee is $201,000
  • PMI BioPharma Solutions's total funding is $23.6M.

Employee Data

  • PMI BioPharma Solutions has 112 Employees.(i)
  • PMI BioPharma Solutions grew their employee count by 12% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$145.5M5170%$28.5MN/A
#2
$102.7M5117%N/AN/A
#3
$58.7M2921%N/AN/A
#4
$8.2M41-2%N/AN/A
#5
$22.5M11212%$23.6MN/A
#6
$5.6M284%N/AN/A
#7
$11.3M568%N/AN/A
#8
$13.1M657%N/AN/A
#9
$7.6M3815%N/AN/A
#10
$7.2M363%N/AN/A
Add Company

PMI BioPharma Solutions LLC is a Contract Development and Manufacturing Organization (CDMO) and research services company headquartered in Nashville, Tennessee. PMI BioPharma Solutions offers a full range of pharmaceutical development and research contract services to small and mid-size pharmaceutical companies. The Nashville facility specializes in bulk liquid and cream manufacturing, aseptic and non-aseptic filling, clinical labeling, analytical development and research and development in protein sciences. The company also has a laboratory facility in Celina, Tennessee, where the main focus is the development of monoclonal antibodies derived from murine models; the site is divided into two departments, Veterinary Resources and the Antibody Laboratory.

keywords:N/A

$23.6M

Total Funding

112

Number of Employees

$22.5M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PMI BioPharma Solutions's People

NameTitleEmail/Phone
1
VP, AdministrationReveal Email/Phone
2
CEOReveal Email/Phone
3
CFOReveal Email/Phone
4
EVP, OperationsReveal Email/Phone
5
SVP, Commercial DevelopmentReveal Email/Phone
Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.2M11233%N/A
#2
$28.4M112-8%N/A
#3
$26.8M11227%N/A
#4
$36M112-4%N/A
#5
$16.2M11220%$17.4M